Growth fraction in centrocytic and follicular center cell lymphomas: Assessment in paraffin sections with a proliferating cell nuclear antigen antibody and morphometric correlates

• Published in: Human pathology Vol. 24; no. 5; pp. 540 - 546
• Main Authors: Swerdlow, Steven H., Westermann, Cindy D., Pelstring, Richard J., Saboorian, M.Hossein, Williams, Michael E.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.05.1993; Elsevier
• Subjects: Biological and medical sciences; Cell Nucleus - ultrastructure; centrocytic lymphoma; Cyclin D1; Gene Rearrangement; growth fraction; Hematologic and hematopoietic diseases; Humans; Immunoenzyme Techniques; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis; Lymphoma, Follicular - genetics; Lymphoma, Follicular - metabolism; Lymphoma, Follicular - pathology; Lymphoma, Non-Hodgkin - genetics; Lymphoma, Non-Hodgkin - metabolism; Lymphoma, Non-Hodgkin - pathology; Medical sciences; morphometry; non-Hodgkin's lymphomas; Nuclear Proteins - metabolism; Paraffin Embedding; Proliferating Cell Nuclear Antigen; proliferating cell nuclear antigen/cyclin; Proto-Oncogene Proteins - genetics; Staining and Labeling; growth fraction; morphometry; centrocytic lymphoma; non-Hodgkin's lymphomas; proliferating cell nuclear antigen/cyclin; Human; Pathology; Lymphoproliferative syndrome; Exploration; Malignant hemopathy; Non Hodgkin lymphoma; Morphometry
• ISSN: 0046-8177; 1532-8392
• DOI: 10.1016/0046-8177(93)90167-F

Measurement of growth fraction is an important way to provide an objective assessment of non-Hodgkin's lymphomas; however, many of the techniques used require fresh tissue and/or special instrumentation. Recently, antibodies to the proliferating cell nuclear antigen (PCNA)/cyclin reactive in paraffin-embedded sections have become available. To investigate the utility of one such antibody in the study of follicular center cell (FCC) lymphomas and cleaved cell lymphomas of centrocytic type (CC), paraffin sections from 40 cases that had been characterized in two previous morphometric studies were stained with a PCNA antibody. Strong correlations were found between PCNA staining in formalin- and B5-fixed tissues, between the overall proportion of PCNA-positive cells and the proportion in the area of greatest staining, and between strong and total staining. Proliferating cell nuclear antigen staining was significantly stronger in the noncleaved FCC lymphomas than in the cleaved cell lymphomas. The FCC lymphomas showed moderate to strong correlations between PCNA staining and morphometric features of transformation, but only nuclear area correlated with PCNA staining in the CC group. Proliferating cell nuclear antigen staining was not significantly different between CC lymphomas with and without the characteristic bcl-1 PRAD 1 gene rearrangement. In summary, PCNA staining of either B5- or formalin-fixed, paraffinembedded tissue sections is a simple aid in the objective categorization of FCC lymphomas and may offer additional potentially prognostic information in some FCC subsets and in CC lymphomas. The findings further support the distinction between CC and true FCC lymphomas.